Sinaptica Therapeutics
PrivateLast Round
Grant
Dec 11, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Sinaptica Therapeutics is a neurotechnology company developing a personalized, non-invasive neuromodulation therapy to treat Alzheimer's and other primary neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Usage-Based SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sinaptica Therapeutics Comparables
Compare Sinaptica Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cognito Therapeutics | 82% | |
| Bottneuro AG | 80% | |
| REGEnLIFE | 76% | |
Sinaptica Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 11, 2025 | ||||
| Convertible Debt | Jul 31, 2025 | ||||
| Seed | Nov 28, 2023 |
Sinaptica Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HealthTech Capital | Convertible Debt, Seed |
| Keiretsu Forum | Convertible Debt |
| Bootstrap Venture Partners | Convertible Debt |
| 1004 Venture Partners | Convertible Debt, Series A |
| Pureland Venture | Convertible Debt |
| Baycrest Hospital | Grant |
| Wilson Sonsini Goodrich & Rosati | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
Monthly visitors increased 43% MoM, reaching 1.6K.
- Dec 11, 2025
Received grant funding from Baycrest Hospital and CABHI.
Sinaptica Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sinaptica Therapeutics's valuation, stock price, and market status.